How do we identify the patients most likely to benefit from a given treatment?

Created by Laura Heiser lmheiser
We are using noninvasive profiling of tumor (circulating tumor DNA) and immune (cellular deconvolution from RNA-seq) parameters to predict response to immune checkpoint blockade.
Test by Lauren

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

How do we identify the patients most likely to benefit from a given treatment?

Drop files to upload

How do we identify the patients most likely to benefit from a given treatment? page is loading…